Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways.

Zhou, GML, Sutton, GM, Rochford, JJ, Semple, RK, Lam, DD, Oksanen, LJ, Thornton-Jones, Zoe, Clifton, Pete, Yueh, CY, Evans, ML, McCrimmon, RJ, Elmquist, JK, Butler, AA and Heisler, LK (2007) Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metabolism, 6. pp. 398-405.

Full text not available from this repository.
Item Type: Article
Schools and Departments: School of Psychology > Psychology
Depositing User: EPrints Services
Date Deposited: 06 Feb 2012 15:32
Last Modified: 30 Nov 2012 16:57
URI: http://sro.sussex.ac.uk/id/eprint/13157
📧 Request an update